8 results
Early Breast Cancer - Management Algorithm
 • Luminal A-like (ER+ and/or PR+, HER2- and low proliferation)
Early Breast Cancer ... Luminal A-like (ER ... Early #Breast #Cancer ... Management #Algorithm #treatment ... #oncology
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
the long-term treatment ... - Naltrexone ER ... /Bupropion ER ... WeightLoss #AACE #2016 #Pharmacology ... #Table #Comparison
Treatment of breast cancer: a simplified view
surgical therapy - 5-7 weeks
 - lumpectomy +
 - radiation
Treatment of breast ... cancer: a simplified ... 10 years - if ER ... #treatment #management ... timeline #simplified #oncology
Breast Cancer Subtypes 
Histological Subtypes:
 • Preinvasive: Ductal carcinoma in situ (DCIS). Lobular carcinoma in situ
Breast Cancer Subtypes ... Triple-negative (ER ... 0111-2 #Breast #Cancer ... #Subtypes #oncology ... #classification
Acute Kidney Injury (AKI) in Patients with Cancer 

Cancer Related 
• Hypercalcemia 
• Intravenous contrast 
•
Patients with Cancer ... Cancer Related ... malignancies Treatment ... #Oncology #Differential ... #Diagnosis #Classification
Testicular Cancer - Treatment Related Toxicities

Bleomycin, Cisplatin, Etoposide, lfosfamide
Tinnitus & Hearing Loss
Neurotoxicity
Pulmonary Fibrosis
Hypotension
Nephrotoxicity
Skin Hyperpigmentation
Hemorrhagic Cystitis
Myelosuppression
Peripheral Neuropathy

Ashley
Testicular Cancer ... - Treatment Related ... #Testicular #Cancer ... toxicology #Toxicities #pharmacology ... #oncology
(DOAC interactions) Cancer-treatment specific inducers (↑) and inhibitors (↓)
of cytochrome p450 CYP3A4 and P-glycoprotein.

DOACs are substrates
interactions) Cancer-treatment ... #Chemotherapy #Oncology ... Interactions #Table #Pharmacology
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
-95% of cases) Classification ... from germinal center ... Hodgkin Lymphoma Treatment ... lymphoma #diagnosis #classification ... #hematology #oncology